SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001842952-24-000003
Filing Date
2024-02-07
Accepted
2024-02-07 16:24:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A cntx-schedule13g_amlehr.htm SC 13G/A 92690
  Complete submission text file 0001842952-24-000003.txt   94141
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Subject) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93112 | Film No.: 24604683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Lehr Martin A. (Filed by) CIK: 0001861989 (see all company filings)

Type: SC 13G/A